Iraq receives 1.2 million doses of the Pfizer–BioNTech COVID-19 vaccine through the COVAX initiative
Iraq receives 1.2 million doses of the Pfizer–BioNTech COVID-19 vaccine through the COVAX initiative.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthIraq receives 1.2 million doses of the Pfizer–BioNTech COVID-19 vaccine through the COVAX initiative
View Premium plansBrowse free archive reportsIraq receives 1.2 million doses of the Pfizer–BioNTech COVID-19 vaccine through the COVAX initiative.